(1)
Đức, L. T.; Lập, B. T. 15. Survival Results of Gemcitabine-Carboplatin Regimen Chemotherapy of Recurrent or Metastatic in Triple Negative Breast Cancer. TCNCYH 2022, 156, 120-129.